Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 6/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17600772 | 1.00 | ABCB1 (0.38) | ABCB1CYP3A4 | |
| SCHEMBL17600919 | 0.87 | ABCB1 (0.37) | ABCB1CYP3A4 | |
| SCHEMBL17600918 | 0.87 | ABCB1 (0.37) | ABCB1CYP3A4 | |
| SCHEMBL20377844 | 0.87 | ABCB1 (0.38) | ABCB1CYP3A4 | |
| SCHEMBL20377843 | 0.87 | ABCB1 (0.38) | ABCB1CYP3A4 | |
| SCHEMBL17600847 | 0.87 | ABCB1 (0.38) | ABCB1CYP3A4 | |
| SCHEMBL17600845 | 0.87 | ABCB1 (0.38) | ABCB1CYP3A4 | |
| SCHEMBL17600786 | 0.86 | ABCB1 (0.35) | ABCB1CYP3A4 | |
| SCHEMBL17600911 | 0.85 | ABCB1 (0.37) | ABCB1CYP3A4 | |
| SCHEMBL17600910 | 0.85 | ABCB1 (0.37) | ABCB1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3194359-B1 | BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS | INTREXON CORP (US) | 2020-04-08 | — | — | EP | disclosed |
| US-10570158-B2 | Boron-containing diacylhydrazine compounds | INTREXON CORPORATION (US) | 2020-02-25 | — | — | US | disclosed |
| US-20180201628-A1 | Boron-Containing Diacylhydrazine Compounds | INTREXON CORP (US) | 2018-07-19 | — | — | US | disclosed |
| US-9944659-B2 | Boron-containing diacylhydrazine compounds | INTREXON CORPORATION (US) | 2018-04-17 | — | — | US | disclosed |
| EP-3194359-A1 | BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS | Intrexon Corporation (US) | 2017-07-26 | — | — | EP | disclosed |
| WO-2016044390-A1 | BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS | INTREXON CORPORATION (US) | 2016-03-24 | — | — | WO | disclosed |
| US-20160083403-A1 | Boron-Containing Diacylhydrazine Compounds | INTREXON CORPORATION | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083403-A1 | Boron-Containing Diacylhydrazine Compounds | BRDT, CD22, BCR | ABCB1 279/4885CYP3A4 3536/4885 |
| US-20180201628-A1 | Boron-Containing Diacylhydrazine Compounds | BRDT, CD22, BCR | ABCB1 279/4885CYP3A4 3536/4885 |
| US-10570158-B2 | Boron-containing diacylhydrazine compounds | BRDT, CD22, BCR | ABCB1 279/4885CYP3A4 3536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.